Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simulated Vaccine Efficacy Trial in High-Risk Women in Zambia
NCT02589678Phase 2Completed
- Sponsor
- Emory University
- Start
- Aug 2015
- Primary completion
- May 2017
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of measles, mumps, and rubella vaccine, tetanus toxoid + diphtheria toxoid + acellular pertussis + inactivated poliovirus vaccine in human immunodeficiency virus infection (HIV), sponsored by Emory University. Started Aug 2015; status: completed.
02
Drugs
measles, mumps, and rubella vaccinetetanus toxoid + diphtheria toxoid + acellular pertussis + inactivated poliovirus vaccine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02589678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02589678.